We are pleased to welcome Mr Calum Mulveen to the Unit as a Research Technician in the Magill Group.

Calum graduated with an M.Sci. (hons.) in Biomedical Sciences from St George’s University of London in 2018. His training included human dissection, basic clinical sciences, and a later specialisation in the area of neuroscience. Calum then worked on a research project focusing on addictive behaviour and neurophysiology, which was carried out through The Erasmus Programme at the Donders Institute for Brain, Cognition and Behaviour in Nijmegen, the Netherlands.

Here in the Unit, Calum’s work will be centred on the development and delivery of novel in vivo platforms for drug discovery in Parkinson’s disease, as part of the Unit’s new translational research venture with partners at the University of Oxford and FORMA Therapeutics.